Virus de la inmunodeficiencia adquirida: tratamiento
Arango, César.
Acta méd. colomb
; 13(4): 293-6, jul.-ago. 1988. tab
Artículo en Español | LILACS | ID: lil-292892
Documentos relacionados
[The treatment of 12 HIV-infected children with zidovudine].
Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese Volunteers.
Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.
Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation.
Third-Generation Transdermal Delivery Systems Containing Zidovudine: Effect of the Combination of Different Chemical Enhancers and a Microemulsion System.
The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
[Azidothymidine in the management of immune deficiency complex].
[Secondary prevention of cytomegalovirus retinitis with ganciclovir].
Summary of the 5th Conference on Retroviruses and Opportunistic Infections.